News Quipt Announces Multi-State Acquisition Adding Approximately $9 Million in Annualized Revenues, and Anticipated $2 Million in Adjusted EBITDA Post Integration Staff September 11, 2023 Iframe sync Post navigation Previous: Scinai Immunotherapeutics Ltd. to participate this week in H.C. Wainwright 25th Annual Global Investment Conference in New York and LSX USA Congress 2023 in BostonNext: Ardelyx Showcased Encouraging Data on Treatment Satisfaction and Efficacy of IBSRELA® (tenapanor) for IBS-C at GHAPP 2023 More Stories Healthcare News Health Care AI Initiative Launched by Paragon Health Institute Staff January 12, 2026 Healthcare News Pharmaceutical Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound Staff January 12, 2026 Clinical Trial Diagnostics Healthcare News Pharmaceutical CelLBxHealth PLC Announces Board Changes Staff January 12, 2026
